Ancora Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.14M | Sell |
88,780
-10,835
| -11% | -$283K | 0.04% | 312 |
|
|
2026
Q1 | $2.8M | Sell |
99,615
-731
| -0.7% | -$19.5K | 0.06% | 243 |
|
|
2025
Q4 | $2.5M | Sell |
100,346
-1,776
| -2% | -$44.8K | 0.05% | 266 |
|
|
2025
Q3 | $2.6M | Sell |
102,122
-7,703
| -7% | -$190K | 0.05% | 247 |
|
|
2025
Q2 | $2.66M | Sell |
109,825
-29,276
| -21% | -$683K | 0.06% | 250 |
|
|
2025
Q1 | $3.52M | Sell |
139,101
-29,133
| -17% | -$762K | 0.08% | 203 |
|
|
2024
Q4 | $4.46M | Sell |
168,234
-79,467
| -32% | -$2.16M | 0.1% | 183 |
|
|
2024
Q3 | $7.17M | Buy |
247,701
+5,155
| +2% | +$150K | 0.16% | 128 |
|
|
2024
Q2 | $6.79M | Sell |
242,546
-12,731
| -5% | -$351K | 0.17% | 123 |
|
|
2024
Q1 | $7.08M | Buy |
255,277
+6,757
| +3% | +$187K | 0.16% | 118 |
|
|
2023
Q4 | $7.15M | Buy |
248,520
+68,102
| +38% | +$2.06M | 0.17% | 121 |
|
|
2023
Q3 | $5.98M | Sell |
180,418
-6,778
| -4% | -$240K | 0.16% | 136 |
|
|
2023
Q2 | $6.87M | Buy |
187,196
+2,558
| +1% | +$99.6K | 0.18% | 113 |
|
|
2023
Q1 | $7.53M | Buy |
184,638
+2,490
| +1% | +$108K | 0.21% | 91 |
|
|
2022
Q4 | $9.33M | Buy |
182,148
+16,810
| +10% | +$806K | 0.27% | 70 |
|
|
2022
Q3 | $7.24M | Buy |
165,338
+2,861
| +2% | +$139K | 0.22% | 89 |
|
|
2022
Q2 | $8.52M | Sell |
162,477
-14,465
| -8% | -$737K | 0.24% | 95 |
|
|
2022
Q1 | $9.16M | Sell |
176,942
-7,187
| -4% | -$373K | 0.22% | 99 |
|
|
2021
Q4 | $10.9M | Sell |
184,129
-771
| -0.4% | -$38.2K | 0.26% | 87 |
|
|
2021
Q3 | $7.95M | Buy |
184,900
+4,188
| +2% | +$186K | 0.21% | 112 |
|
|
2021
Q2 | $7.08M | Buy |
180,712
+1,952
| +1% | +$75.9K | 0.18% | 121 |
|
|
2021
Q1 | $6.48M | Buy |
178,760
+12,079
| +7% | +$429K | 0.18% | 129 |
|
|
2020
Q4 | $6.14M | Buy |
166,681
+15,935
| +11% | +$585K | 0.2% | 130 |
|
|
2020
Q3 | $5.25M | Buy |
150,746
+14,585
| +11% | +$511K | 0.21% | 117 |
|
|
2020
Q2 | $4.22M | Sell |
136,161
-13,447
| -9% | -$457K | 0.18% | 132 |
|
|
2020
Q1 | $4.63M | Sell |
149,608
-14,118
| -9% | -$481K | 0.21% | 120 |
|
|
2019
Q4 | $6.09M | Sell |
163,726
-244,183
| -60% | -$8.7M | 0.23% | 125 |
|
|
2019
Q3 | $13.9M | Buy |
407,909
+9,801
| +2% | +$356K | 0.61% | 41 |
|
|
2019
Q2 | $16.4M | Buy |
398,108
+6,753
| +2% | +$268K | 0.73% | 33 |
|
|
2019
Q1 | $15.8M | Buy |
391,355
+12,596
| +3% | +$504K | 0.72% | 34 |
|
|
2018
Q4 | $15.7M | Buy |
378,759
+4,252
| +1% | +$177K | 0.75% | 27 |
|
|
2018
Q3 | $15.7M | Buy |
374,507
+67,949
| +22% | +$2.62M | 0.6% | 39 |
|
|
2018
Q2 | $10.6M | Buy |
306,558
+1,467
| +0.5% | +$50.1K | 0.46% | 68 |
|
|
2018
Q1 | $10.3M | Buy |
305,091
+8,581
| +3% | +$295K | 0.46% | 64 |
|
|
2017
Q4 | $10.2M | Buy |
296,510
+16,902
| +6% | +$576K | 0.54% | 47 |
|
|
2017
Q3 | $9.47M | Buy |
279,608
+20,231
| +8% | +$650K | 0.55% | 42 |
|
|
2017
Q2 | $8.27M | Buy |
259,377
+3,269
| +1% | +$103K | 0.54% | 43 |
|
|
2017
Q1 | $8.31M | Sell |
256,108
-1,085
| -0.4% | -$34.2K | 0.56% | 41 |
|
|
2016
Q4 | $7.93M | Buy |
257,193
+60,696
| +31% | +$1.85M | 0.58% | 36 |
|
|
2016
Q3 | $6.31M | Buy |
196,497
+2,381
| +1% | +$79.6K | 0.64% | 27 |
|
|
2016
Q2 | $6.49M | Sell |
194,116
-938
| -0.5% | -$29.9K | 0.75% | 24 |
|
|
2016
Q1 | $5.49M | Buy |
195,054
+1,386
| +0.7% | +$39.6K | 0.67% | 31 |
|
|
2015
Q4 | $5.93M | Buy |
193,668
+693
| +0.4% | +$21.8K | 0.76% | 24 |
|
|
2015
Q3 | $5.75M | Buy |
192,975
+9
| +0% | +$289 | 0.74% | 24 |
|
|
2015
Q2 | $6.14M | Buy |
+192,966
| New | +$6.29M | 0.72% | 29 |
|
|
2015
Q1 | – | Sell |
-196,213
| Closed | -$6.24M | – | 24 |
|
|
2014
Q4 | $5.8M | Sell |
196,213
-4,876
| -2% | -$140K | 0.71% | 33 |
|
|
2014
Q3 | $5.64M | Sell |
201,089
-1,033
| -0.5% | -$29K | 0.72% | 31 |
|
|
2014
Q2 | $5.69M | Sell |
202,122
-393
| -0.2% | -$11.2K | 0.74% | 27 |
|
|
2014
Q1 | $6.17M | Buy |
202,515
+11,331
| +6% | +$338K | 0.87% | 20 |
|
|
2013
Q4 | $5.56M | Buy |
191,184
+4,559
| +2% | +$133K | 0.84% | 24 |
|
|
2013
Q3 | $5.09M | Sell |
186,625
-21,983
| -11% | -$598K | 0.87% | 22 |
|
|
2013
Q2 | $5.54M | Buy |
+208,608
| New | +$5.76M | 0.95% | 22 |
|
Other funds holding PFE
Ancora Advisors's PFE Position: Q2 2026 in Review
Ancora Advisors reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $283K and leaving 88,780 shares worth $2.14M. The position accounts for 0.04% of the portfolio, ranked #312.
Ancora Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.4M in Q2 2019. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ancora Advisors held 88,780 shares of Pfizer worth $2.14M as of Q2 2026.
- Ancora Advisors sold 10,835 Pfizer shares in Q2 2026, an estimated $283K.
- Pfizer made up 0.04% of Ancora Advisors's portfolio in Q2 2026, its #312 holding.
- Ancora Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Ancora Advisors's Pfizer position peaked at $16.4M in Q2 2019.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.